Skip to content
The Policy VaultThe Policy Vault

Imkeldi (imatinib oral solution) — Medica

Chronic graft-versus-host disease

Initial criteria

  • Patient has tried at least one conventional systemic treatment for graft-versus-host disease

Approval duration

1 year